Section Arrow
Quote
MEDP.NASDAQ
- Medpace Holdings
Quotes are at least 15-min delayed:2025/09/18 04:15 EDT
Pre Market
Last
 --
-- (--)
Bid
450.1
Ask
796.52
High -- 
Low -- 
Volume -- 
Regular Hours
Last
 497.83
+7.06 (+1.44%)
Day High 
506.5499 
Prev. Close
490.77 
1-M High
499.65 
Volume 
294.61K 
Bid
450.1
Ask
796.52
Day Low
485.54 
Open
488.47 
1-M Low
452.77 
Market Cap 
13.79B 
Currency USD 
P/E 36.46 
%Yield -- 
10-SMA 488.03 
20-SMA 477.83 
50-SMA 433.31 
52-W High 506.5499 
52-W Low 250.05 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
13.46/14.79
Enterprise Value
13.91B
Balance Sheet
Book Value Per Share
6.14
Cash Flow
Cash Flow Yield
0.04
Income Statement
Total Revenue
2.11B
Operating Revenue Per Share
63.42
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
BIAFbioAffinity Technologies0.1826-0.0784-30.04%-- 
Pre Market 0.1835 +0.0009 +0.49%
NEOGNeogen Corp5.46+0.19+3.61%879PE
Pre Market -- -- --
DHRDanaher Corp192.94+2.47+1.30%40.44PE
Pre Market -- -- --
NEONeoGenomics8.11+0.12+1.50%-- 
Pre Market -- -- --
CHEKCheck-Cap Ltd2.32-0.2-7.94%-- 
Pre Market 2.16 -0.16 -6.90%
Quotes are at least 15-min delayed：2025/09/18 04:15 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services,including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.